• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
MODEL QUESTION PAPER “Do not write anything on question
MODEL QUESTION PAPER “Do not write anything on question

... Write short notes on the following (any four): (a) Handling of a prescription (b) Factors influencing dose calculation (c) Instabilities in an emulsion (d) Advantages and disadvantages of a suppository (e) Total parenteral nutrition ...
Delayed Drug Effects - Professor Nick Holford
Delayed Drug Effects - Professor Nick Holford

... measure drug concentration at the site of action the time course of distribution can be described empirically by proposing an effect compartment. The time course of observed drug effect is then used to deduce the time course of drug concentration at the site of action. The simplest model for an effe ...
test cross
test cross

... Heterozygous snapdragons have 2 sets of instructions: will turn out pink ...
the benefits of incremental innovation
the benefits of incremental innovation

... patient group, it is certainly much better to have many options, where the physician can match the patient with the best medicine, than only a single choice which may or may not be suitable for certain patients. In order to be accepted within the class, each new drug must also represent some cumulat ...
Bontril - MedConnections
Bontril - MedConnections

... Phendimetrazine tartrate is a sympathomimetic amine with pharmacological activity similar to the prototype drugs of this class used in obesity, the amphetamines. Actions include central nervous system stimulation and elevation of blood pressure. Tachyphylaxis and tolerance have been demonstrated wit ...
Position Statement on the Return and Reuse of Prescription
Position Statement on the Return and Reuse of Prescription

... initiative. Equally vital is educating health care providers on the importance of prescribing and dispensing appropriate quantities, particularly limiting quantities for acute therapy and in the ...
HYPNOTIC - SEDATIVE DRUGS Dra. Ma. Shiela C
HYPNOTIC - SEDATIVE DRUGS Dra. Ma. Shiela C

... > Amnesic effects & next-day psychomotor impairment may occur ...
Document
Document

... Controlled Substances: The DEA requires that a complete inventory of all controlled substances must be taken every 2 years. Some states have more stringent requirements such as a yearly inventory. The complete inventory must include an inventory record and an extemporaneous compounding record. ...
Dangers in Herbs-Drug Interactions
Dangers in Herbs-Drug Interactions

... Challenges with evidence related to herb-drug interactions  Many published studies lack rigorous design  May not reflect how complementary medicines are used in practice  Not conducted in the patient group of interest  Product quality and variability is a key concern  Ginkgo biloba (based on E ...
File
File

... – Offspring resulting from cross between organism with a HOMOZYGOUS Dominant parent and a HOMOZYGOUS recessive ...
retinitis pigmentosa research advances
retinitis pigmentosa research advances

... commercialize the treatment and gene therapies for other ocular diseases. The Foundation funded much of the preclinical research that made these LCA gene-therapy clinical trials possible. FDA-Approved Drug in Clinical Trial for Dominant Retinitis Pigmentosa Valproic acid, a drug which has shown pote ...
Neuromodulation for Failed Back Surgery
Neuromodulation for Failed Back Surgery

... the outcome measure emphasized. There is a “disconnect” between ratings of pain, disability, mood, and quality of life. The use of a multi-dimensional outcomes approach revealed a number of inconsistencies in the data which could have been overlooked using only pain ratings and patient satisfaction ...
The Role of the MDI and DPI in Pediatric Patients
The Role of the MDI and DPI in Pediatric Patients

... this age group, consider combining breath-actuated MDI ␤ agonist and a DPI corticosteroid when the patient requires both of these classes of drugs. The other important difference is greater potential for an adverse effect on growth with inhaled corticosteroids. While it is widely accepted that inhal ...
Consumer Updates > FDA Warns of Health Risks Posed by E
Consumer Updates > FDA Warns of Health Risks Posed by E

... cigarettes. Also known as “e-cigarettes,” electronic cigarettes are battery-operated devices designed to look like and to be used in the same manner as conventional cigarettes. Sold online and in many shopping malls, the devices generally contain cartridges filled with nicotine, flavor, and other ch ...
HMG-CoA reductase inhibitor pharmacogenomics: overview and
HMG-CoA reductase inhibitor pharmacogenomics: overview and

... from Geisel and colleagues that showed no difference in LDL cholesterol reduction to simvastatin 40 mg among CYP2D6 poor, intermediate, extensive, and ultra-rapid metabolizers [14]. This raises several important issues in the consideration of genotype-assigned drug-metabolizing phenotype as a predic ...
Using proton-pump inhibitors among haemodialysis patients
Using proton-pump inhibitors among haemodialysis patients

... admitted taking drugs “as needed”, however occasional use of PPI does not provide appropriate acid inhibition and clinical response as well [28,29]. High daily pill burden increases the problem of lack of compliance. The more pills are prescribed, the more possible it is to skip portions of drugs by ...
Gregor Mendel Power Point File
Gregor Mendel Power Point File

...  TT - Represent offspring with straight hair  Tt - Represent offspring with straight hair  tt - Represents offspring with curly hair ...
Get the facts - United Nations Office on Drugs and Crime
Get the facts - United Nations Office on Drugs and Crime

... with impurities, meaning each dose is different. ...
Surviving War and Woodstock
Surviving War and Woodstock

... An estimated 1 in 5 older adults may be adversely affected by a combination of alcohol and medication misuse. Approximately 25% of older adults use prescription psychoactive medications that have a potential to be misused or abused. Misuse of prescription medications among older adults, which is est ...
Oxcarbazepine (TrileptalTM)
Oxcarbazepine (TrileptalTM)

... FDA’s commitment to generic medicines  “FDA will continue to make the generic drug approval process more efficient with the goal of lowering national health care costs by reducing the cost of bringing safe and effective generic drugs to market.” FDA press release August 8, 2003 Belief by payers, so ...
HIVTRI workshop: Treatment information for doctors and
HIVTRI workshop: Treatment information for doctors and

... • timeline for newer drugs • timeline for new strategies ...
Chapter 4: States of Consciousness
Chapter 4: States of Consciousness

... Two of the top 4 substances are legal Marijuana is lowest on this list, but a schedule 1 drug. Keep in mind long term consequences were not included. ...
Standardizing terms for clinical pharmacogenetic test results
Standardizing terms for clinical pharmacogenetic test results

... into value sets, which together described the range of pos­ sible descriptors of alleles or phenotypes. These value sets were evaluated in surveys 2 through 4, and the top value sets were retained until 70% consensus was reached. For surveys 1 and 2, genes that encode enzymes with similar metabolic ...
Antiarrhythmic Drugs
Antiarrhythmic Drugs

... • Highly bound to plasma proteins • Metabolized in liver ( active metabolite) • 20% excreted unchanged in urine • Usually given as slow release formulation • I.M. painful, I.V(marked hypotension) ...
Huntington`s disease
Huntington`s disease

... important inherited cause of chorea discovered by George Huntingtonin 1872. In 1993, the causative gene defect was identified as a CAG triplet repeat expansion mutation in the HD gene on chromosome 4. Onset is usually in adult life with a mean age of about 40 years It progresses inexorably, with dea ...
< 1 ... 855 856 857 858 859 860 861 862 863 ... 1254 >

Pharmacogenomics

Pharmacogenomics (a portmanteau of pharmacology and genomics) is the study of the role of genetics in drug response. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with drug absorption, distribution, metabolism and elimination, as well as drug receptor target effects. The term pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.Pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Through the utilization of pharmacogenomics, it is hoped that drug treatments can deviate from what is dubbed as the “one-dose-fits-all” approach. It attempts to eliminate the trial-and-error method of prescribing, allowing physicians to take into consideration their patient’s genes, the functionality of these genes, and how this may affect the efficacy of the patient’s current and/or future treatments (and where applicable, provide an explanation for the failure of past treatments). Such approaches promise the advent of ""personalized medicine""; in which drugs and drug combinations are optimized for each individual's unique genetic makeup. Whether used to explain a patient’s response or lack thereof to a treatment, or act as a predictive tool, it hopes to achieve better treatment outcomes, greater efficacy, minimization of the occurrence of drug toxicities and adverse drug reactions (ADRs). For patients who have lack of therapeutic response to a treatment, alternative therapies can be prescribed that would best suit their requirements. In order to provide pharmacogenomic-based recommendations for a given drug, two possible types of input can be used: genotyping or exome or whole genome sequencing. Sequencing provides many more data points, including detection of mutations that prematurely terminate the synthesized protein (early stop codon).
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report